【摘要】 采用酶联免疫吸附试验（ＥＬＩＳＡ）检测８４例肝癌病人和８０例非肝癌病人血清中的戊型肝炎抗体（抗－ＨＥＶ）、丙型肝炎抗体（抗－ＨＣＶ）和乙肝表面抗原（ＨＢｓＡｇ）。结果：两种人群相应抗体抗原的阳性率依次为：１０．７％、３０．０％、８０．１％和５．０％、５．０％、１０．０％，两组比较，相应阳性率的Ｐ值分别为Ｐ＞０．０５，Ｐ＜０．０１，Ｐ＜０．０１，ＯＲ值分别为１．１、６、８。认为：肝癌病人存在着ＨＥＶ感染；肝癌发生仍以ＨＢＶ感染关系最密切，次为ＨＣＶ感染，与ＨＥＶ感染关系不大。更多还原

【Abstract】 Serum anti HEV,anti HCV and HBsAg of 84 primary liver cancer patients and 80 non primary liver cancer patients from the same regions of high prevalence of liver cancer in Guangxi were tested by ELISA Result:the positive rates of anti HEV,anti HCV and HBsAg of the liver cancer group were respectively 10 7%,30 0%,80 1% and those of the non liver cancer group were respectively 5 0%,5 0%,10 0% The differences between these two groups were significant(P>0 05,P<0 01,P<0 01).Their OR values were respectively 1 1,6 and 8.The result shown that HEV infection exists in patients with primary liver cancer HBV infection correlates best with the pathogenesis of primary liver cancer;second comes HCV infection;and there seems not much correlation between HEV infection and primary liver cancer更多还原